Zynex Price to Free Cash Flow Ratio 2010-2025 | ZYXI
Historical price to free cash flow ratio values for Zynex (ZYXI) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Zynex Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-06-20 | 2.49 | 0.00 | |
| 2025-03-31 | 2.20 | $-0.02 | 0.00 |
| 2024-12-31 | 8.01 | $0.38 | 21.30 |
| 2024-09-30 | 8.16 | $0.46 | 17.59 |
| 2024-06-30 | 9.32 | $0.49 | 19.10 |
| 2024-03-31 | 12.37 | $0.47 | 26.29 |
| 2023-12-31 | 10.89 | $0.46 | 23.71 |
| 2023-09-30 | 8.00 | $0.42 | 18.94 |
| 2023-06-30 | 9.59 | $0.37 | 26.05 |
| 2023-03-31 | 12.00 | $0.35 | 34.60 |
| 2022-12-31 | 13.91 | $0.34 | 40.84 |
| 2022-09-30 | 9.07 | $0.41 | 22.11 |
| 2022-06-30 | 7.98 | $0.31 | 25.40 |
| 2022-03-31 | 6.23 | $0.35 | 17.87 |
| 2021-12-31 | 8.14 | $0.16 | 50.34 |
| 2021-09-30 | 9.30 | $-0.08 | 0.00 |
| 2021-06-30 | 12.68 | $-0.19 | 0.00 |
| 2021-03-31 | 12.47 | $-0.16 | 0.00 |
| 2020-12-31 | 10.99 | $0.00 | 0.00 |
| 2020-09-30 | 14.25 | $0.10 | 141.48 |
| 2020-06-30 | 20.31 | $0.17 | 116.50 |
| 2020-03-31 | 9.04 | $0.13 | 71.17 |
| 2019-12-31 | 6.43 | $0.16 | 39.09 |
| 2019-09-30 | 7.76 | $0.17 | 44.73 |
| 2019-06-30 | 7.34 | $0.20 | 36.25 |
| 2019-03-31 | 3.67 | $0.25 | 14.90 |
| 2018-12-31 | 2.40 | $0.22 | 10.80 |
| 2018-09-30 | 2.36 | $0.26 | 9.20 |
| 2018-06-30 | 2.46 | $0.25 | 9.72 |
| 2018-03-31 | 2.69 | $0.25 | 10.89 |
| 2017-12-31 | 2.52 | $0.22 | 11.26 |
| 2017-09-30 | 1.47 | $0.14 | 10.69 |
| 2017-06-30 | 0.48 | $0.07 | 6.53 |
| 2017-03-31 | 0.24 | $0.02 | 9.97 |
| 2016-12-31 | 0.24 | $0.04 | 5.30 |
| 2016-09-30 | 0.25 | $0.04 | 6.16 |
| 2016-06-30 | 0.19 | $0.04 | 4.98 |
| 2016-03-31 | 0.27 | $0.02 | 10.82 |
| 2015-12-31 | 0.36 | $0.01 | 35.21 |
| 2015-09-30 | 0.14 | $-0.01 | 0.00 |
| 2015-06-30 | 0.16 | $-0.01 | 0.00 |
| 2015-03-31 | 0.11 | $0.03 | 4.28 |
| 2014-12-31 | 0.13 | $0.02 | 6.51 |
| 2014-09-30 | 0.12 | $0.04 | 2.90 |
| 2014-06-30 | 0.23 | $0.04 | 6.46 |
| 2014-03-31 | 0.18 | $0.00 | 0.00 |
| 2013-12-31 | 0.15 | $-0.03 | 0.00 |
| 2013-09-30 | 0.11 | $-0.04 | 0.00 |
| 2013-06-30 | 0.20 | $-0.04 | 0.00 |
| 2013-03-31 | 0.24 | $-0.05 | 0.00 |
| 2012-12-31 | 0.29 | $-0.05 | 0.00 |
| 2012-09-30 | 0.33 | $-0.04 | 0.00 |
| 2012-06-30 | 0.34 | $-0.05 | 0.00 |
| 2012-03-31 | 0.33 | $-0.05 | 0.00 |
| 2011-12-31 | 0.28 | $-0.05 | 0.00 |
| 2011-09-30 | 0.32 | $-0.06 | 0.00 |
| 2011-06-30 | 0.36 | $-0.04 | 0.00 |
| 2011-03-31 | 0.29 | $-0.04 | 0.00 |
| 2010-12-31 | 0.24 | $-0.04 | 0.00 |
| 2010-09-30 | 0.21 | $0.02 | 10.51 |
| 2010-06-30 | 0.24 | $0.03 | 9.39 |
| 2010-03-31 | 0.37 | $0.04 | 9.69 |
| 2009-12-31 | 0.43 | $0.08 | 5.37 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.075B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.381B | 27.82 |
| Boston Scientific (BSX) | United States | $149.868B | 37.52 |
| Stryker (SYK) | United States | $143.347B | 29.97 |
| EssilorLuxottica (ESLOY) | France | $128.152B | 0.00 |
| Medtronic (MDT) | Ireland | $110.735B | 15.70 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.273B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.835B | 26.69 |
| ResMed (RMD) | United States | $37.196B | 27.94 |
| Agilent Technologies (A) | United States | $32.827B | 21.40 |
| GE HealthCare Technologies (GEHC) | United States | $32.638B | 15.50 |
| Terumo (TRUMY) | Japan | $26.398B | 34.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.463B | 15.06 |
| Insulet (PODD) | United States | $21.334B | 83.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.048B | 11.59 |
| Baxter (BAX) | United States | $15.390B | 11.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.627B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.442B | 22.42 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $4.123B | 18.42 |
| Perrigo (PRGO) | Ireland | $3.643B | 9.23 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.415B | 15.55 |
| Envista Holdings (NVST) | United States | $3.202B | 26.61 |
| ICU Medical (ICUI) | United States | $3.144B | 23.18 |
| QuidelOrtho (QDEL) | United States | $1.896B | 13.04 |
| LeMaitre Vascular (LMAT) | United States | $1.848B | 41.30 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.324B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.132B | 11.49 |
| Neogen (NEOG) | United States | $1.072B | 13.72 |
| Green Thumb Industries (GTBIF) | United States | $1.042B | 23.43 |
| BioLife Solutions (BLFS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.37 |
| InMode (INMD) | Israel | $0.839B | 8.46 |
| Kestra Medical Technologies (KMTS) | United States | $0.772B | 0.00 |
| CeriBell (CBLL) | United States | $0.647B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Owens & Minor (OMI) | United States | $0.567B | 4.71 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.525B | 0.00 |
| Valneva SE (VALN) | France | $0.478B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.377B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.362B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.319B | 11.74 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.307B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.288B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.262B | 22.07 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.13 |
| Sanara MedTech (SMTI) | United States | $0.242B | 0.00 |
| Quanterix (QTRX) | United States | $0.238B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.229B | 68.00 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.217B | 6.09 |
| Cresco Labs (CRLBF) | United States | $0.212B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.212B | 0.00 |
| Brainsway (BWAY) | Israel | $0.206B | 54.55 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.19 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Organigram Global (OGI) | Canada | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.132B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.125B | 15.40 |
| Jin Medical (ZJYL) | China | $0.095B | 0.00 |
| Veru (VERU) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.34 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.083B | 0.00 |
| Agape ATP (ATPC) | $0.079B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Apyx Medical (APYX) | United States | $0.076B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| ImmuCell (ICCC) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Nephros (NEPH) | United States | $0.053B | 71.43 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 12.98 |
| Rockwell Medical (RMTI) | United States | $0.030B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.011B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |